Endogenous lipoid pneumonia associated with Legionella pneumophila serogroup 1.

Abstract

Endogenous lipoid pneumonia is an uncommon condition. This is a report of a 29-year-old woman diagnosed with endogenous lipoid pneumonia associated with Legionella pneumophila serogroup 1 infection. The patient's endogenous lipoid pneumonia resolved completely after treatment for Legionella pneumophila infection. This suggests that early diagnosis and aggressive treatment of the underlying infection may prevent any long-term sequelae of lipoid pneumonia.

• Authors: Chee-Kin Hui
• Journal: Singapore medical journal (Singapore Med J) Vol. 54 Issue 3 Pg. e66-7 (Mar 2013) ISSN: 0037-5675 [Print] India
• PMID: 23546039 (Publication Type: Case Reports, Journal Article)

Chemical References

• Anti-Bacterial Agents
• Aza Compounds
• Fluoroquinolones
• Quinolines
• Azithromycin
• Moxifloxacin

Topics

• Adult
• Anti-Bacterial Agents (therapeutic use)
• Aza Compounds (therapeutic use)
• Azithromycin (therapeutic use)
• Female
• Fluoroquinolones
• Humans
• Legionella pneumophila (classification)
• Legionnaires' Disease (diagnosis, drug therapy, microbiology)
• Moxifloxacin
• Pneumonia, Lipid (diagnosis, drug therapy, microbiology)
• Quinolines (therapeutic use)
• Treatment Outcome